Sequential therapy using cyclosporine and acitretin for treatment of total body psoriasis

Cutis

Volumn 74, Issue 3, 2004, Pages 185-188

  Short, Matthew W ^a   Vaughan, Thomas K ^b  

^a Bayne Jones Army Community Hospital   (United States)

^b MADIGAN ARMY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; ETRETIN; METHOTREXATE;

ADULT; ARTICLE; CASE REPORT; DISEASE EXACERBATION; HUMAN; MALE; PSORIASIS; RISK ASSESSMENT; TREATMENT FAILURE; TREATMENT OUTCOME;

ACITRETIN; ADMINISTRATION, CUTANEOUS; ADULT; CYCLOSPORINE; DERMATOLOGIC AGENTS; HUMANS; KERATOLYTIC AGENTS; MALE; PSORIASIS; SKIN; TREATMENT OUTCOME;

EID: 4944256670     PISSN: 00114162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Koo J. Systemic sequential therapy of psoriasis: a new paradigm for improved therapeutic results. J Am Acad Dermatol. 1999;41:S25-S28.
2. Drug approvals for June 1997. US Food and Drug Administration Web Site. Available at: http://www.fda.gov /cder/da/da0697.htm. Accessed June 16, 2003.
3. Ellis CN, Fradin MS, Messana JM. Cyclosporine for plaque-type psoriasis: results of a multidose, double-blind trial. N Engl J Med. 1991;324:277-284.
4. Grossman RM, Chevret S, Abi-Rached J, et al. Long-term safety of cyclosporine in the treatment of psoriasis. Arch Dermatol. 1996;132:623-629.
5. Lebwohl M, Ellis C, Gottlieb A. Cyclosporine consensus conference: with emphasis on the treatment of psoriasis. J Am Acad Dermatol. 1998;39:464-475.
6. Gupta AK, Goldfarb MT, Ellis CN, et al. Side-effect profile of acitretin therapy in psoriasis. J Am Acad Dermatol. 1989;20:1088-1093.
7. Pilkington T, Brodgen RN. Acitretin: a review of its pharmacology and therapeutic use. Drugs. 1992;43:597-627.
8. Soriatane [package insert]. Nutley, NJ: Roche Laboratories; 1997.
9. Vahlquist C, Olsson AG, Lindholm A, et al. Effects of gemfibrozil (Lopid) on hyperlipidemia in acitretin-treated patients: results of a double-blind cross-over study. Acta Derm Venereol. 1995;75:377-380.
10. Georgouras KE, Zagarella SS, Cains GD, et al. Systemic treatment of severe psoriasis. Australas J Dermatol. 1997;38:171-182.
11. Koo J, Nguyen Q, Gambla C. Advances in psoriasis therapy. Adv Dermatol. 1997;12:47-72.
12. Mosby's Drug Consult, 2003. Available at: http://home.mdconsult.com/das/ drug/view/29360660. Accessed June 16, 2003.
13. Krueger JG. The immunologic basis for the treatment of psoriasis with new biologic agents. J Am Acad Dermatol. 2002;46:1-23.